Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Tuesday, July 1, 2025
Apellis’s $300 Million Royalty Financing
BioMarin’s $270 Million Acquisition of Inozyme
Nektar’s $100 Million Public Offering
Concentra’s $82 Million Acquisition of IGM
Monday, June 30, 2025
AbbVie’s $2.1 Billion Acquisition of Capstan
BridgeBio’s $300 Million Royalty Financing
Dyne’s $200 Million Public Offering & $275 Million Debt Financing
Gallant’s $18 Million Series B
Friday, June 27, 2025
Channel’s Merger with Pelthos and $50 Million Private Placement
XOMA’s $8 Million Acquisition of Turnstone…More
Bone’s $5 Million Public Offering
InMed’s $5 Million Private Placement
Thursday, June 26, 2025
Kymera’s $250 Million Public Offering
Reviva’s $10 Million Public Offering
Artelo’s $1 Million Private Placement
XORTX $925 Thousand Private Placement
Wednesday, June 25, 2025
Forte’s $75 Million Public Offering
ZyVersa’s $10 Million Asset Sale
Ovid’s $7 Million Royalty Financing
Tuesday, June 24, 2025
Candel’s $15 Million Registered Direct Offering
Revolution’s $2 Billion Royalty and Debt Financing
OutSee’s $2 Million Seed Round
Monday, June 23, 2025
Cidara’s $250 Million Public Offering
Thermo Fisher’s $95 Million Grant
Infinity’s $8 Million Series A
Saturday, June 21, 2025
Cyclacel’s $3 Million Private Placement
Friday, June 20, 2025
Shuttle’s $4 Million Private Placement
Wednesday, June 18, 2025
Actio’s $66 Million Series B…More
Tuesday, June 17, 2025
PolyPid’s $27 Million Warrant Exercise
Biomea’s $19 Million Public Offering
Celltrio’s $15 Million Venture Financing
Sponsors
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck